Causes and Predisposing Factors of De Novo Tumors in Our Series of Liver Transplant Recipients

被引:14
|
作者
Tallon Aguilar, L. [1 ]
Barrera Pulido, L. [1 ]
Bernal Bellido, C. [1 ]
Pareja Ciuro, F. [1 ]
Suarez Artacho, G. [1 ]
Alamo Martinez, J. M. [1 ]
Garcia Gonzalez, I. [1 ]
Gomez Bravo, M. A. [1 ]
Bernardos Rodriguez, A. [1 ]
机构
[1] Hosp Univ Virgen Rocio, Liver Transplant & Hepatobiliopancreat Surg Unit, Gen & Gastrointestinal Surg Dept, Seville, Spain
关键词
D O I
10.1016/j.transproceed.2009.05.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction. Liver transplant recipients suffer a high risk of developing cancer, mainly as a consequence of immunosuppressant treatment, although a variety of other factors are involved. Our purposes were to evaluate the frequency of de novo tumours and to determine predisposing factors. Material and Methods. We analyzed all of the transplantations performed during 1990, with a total of almost 700 cases. We analyzed the frequency of de novo tumors, their location, time since transplantation, survival, and recurrence rates and factors that may influence their appearance. Results. The series included 64 cases in 50 patients with a frequency of 7%. Skin tumors were the most frequent (39.06%), followed by those in the otolaryngologic (ear, nose, and throat) region (15.62%) and the lung (14.06%). The average time to progression between the transplantation and diagnosis was less than 4 years (47.74 months). The recurrence rate was 16%. The factors with the greatest influence on their appearance were age and gender of the recipient, alcohol consumption, and Child-Pugh score. Plasma transfusion was statistically, although not clinically, significant. Discussion. Our frequency of de novo tumors was consistent with that described in the literature. Despite some factors that influence their appearance, the main predisposing factor was immunosuppression and its duration.
引用
收藏
页码:2453 / 2454
页数:2
相关论文
共 50 条
  • [41] EARLY WITHDRAWAL OF CALCINEURIN INHIBITORS AND EVEROLIMUS MONOTHERAPY IN DE NOVO LIVER TRANSPLANT RECIPIENTS
    Montalti, Roberto
    Rompianesi, Gianluca
    Masetti, Michele
    Di Benedetto, Fabrizio
    Cautero, Nicola
    De Ruvo, Nicola
    Guerrini, Gian Piero
    Ballarin, Roberto
    Smerieri, Nazareno
    Gerunda, Giorgio E.
    LIVER TRANSPLANTATION, 2009, 15 (07) : S96 - S97
  • [42] Unmasking the danger: Investigating factors predisposing liver transplant recipients to invasive fungal infections.
    Katheresan, V
    Ramakrishna, Somashekarahosaagrahara
    Malleeswaran, Selvakumar
    Varghese, Joy
    Patcha, Rajanikanth, V
    Kasala, Mohan Babu
    Kumar, Sathish
    Balachandran, Gayatri
    Reddy, Mettu Srinivas
    TRANSPLANTATION, 2024, 108 (9S)
  • [43] EFFICACY AND SAFETY OF THE PKC-INHIBITOR SOTRASTAURIN IN DE NOVO LIVER TRANSPLANT RECIPIENTS
    Pascher, Andreas
    De Simone, Paolo
    Pratschke, Johann
    Salame, Ephrem
    Gopalakrishnan, Unmesh
    Krishnan, Induja
    Klupp, Jochen
    TRANSPLANT INTERNATIONAL, 2013, 26 : 146 - 146
  • [44] RENAL-TRANSPLANT RECIPIENTS AND CHRONIC LIVER-DISEASE - STATISTICAL EVALUATION OF PREDISPOSING FACTORS
    AROLDI, A
    TARANTINO, A
    MONTAGNINO, G
    PAPARELLA, M
    CESANA, B
    RUMI, MG
    PONTICELLI, C
    NEPHRON, 1992, 61 (03): : 290 - 292
  • [45] Comparison of De Novo Cancer Incidence in Australian Liver, Heart and Lung Transplant Recipients
    Na, R.
    Grulich, A. E.
    Meagher, N. S.
    McCaughan, G. W.
    Keogh, A. M.
    Vajdic, C. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (01) : 174 - 183
  • [46] Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients
    Dunn, SP
    Cooney, GF
    Kulinsky, A
    Falkenstein, K
    Pierson, A
    Elder, CA
    Meligeni, J
    TRANSPLANTATION, 1995, 60 (12) : 1438 - 1442
  • [47] Intrahepatic De Novo Tumors in Liver Recipients are Highly Associated With Recurrent Viral Hepatitis
    Pflueger, Michael J.
    Maurer, Max M.
    Hillebrandt, Karl H.
    Andreou, Andreas
    Geisel, Dominik
    Schmelzle, Moritz
    Pratschke, Johann
    Eurich, Dennis
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 11 (04) : 435 - 442
  • [48] Factors influencing dosing and concentrations of sirolimus in de novo heart transplant recipients.
    Akhlaghi, F
    Zahir, H
    Keogh, AM
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 169 - 169
  • [49] De novo sarcomas in solid organ transplant recipients
    Husted, TL
    Buell, JF
    Hanaway, MJ
    Trofe, J
    Beebe, T
    Gross, T
    First, MR
    Woodle, ES
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1786 - 1787
  • [50] Incidence and predisposing factors for "engraftment syndrome" in paediatric transplant recipients
    Schmid, I
    Albert, M
    Stachel, D
    BONE MARROW TRANSPLANTATION, 2006, 37 : S205 - S205